Get the Stockscreener App
163.91
2.80%
-4.88
Icon Plc stock is traded at $163.91, with a volume of 305.06K.
It is down -2.80% in the last 24 hours and down -15.38% over the past month.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
See More
Previous Close:
$168.79
Open:
$166.89
24h Volume:
305.06K
Relative Volume:
0.30
Market Cap:
$13.24B
Revenue:
$8.19B
Net Income/Loss:
$758.19M
P/E Ratio:
17.86
EPS:
9.18
Net Cash Flow:
$1.06B
1W Performance:
-7.69%
1M Performance:
-15.38%
6M Performance:
+14.77%
1Y Performance:
-25.01%
1-Day Range:
$163.74
$168.67
1-Week Range:
$162.36
$177.51
52-Week Range:
$125.10
$231.89
Icon Plc Stock (ICLR) Company Profile
Compare ICLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
163.91 | 12.89B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
564.62 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.39 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.65 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.87 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
212.04 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
Icon Plc $ICLR Shares Acquired by Cambiar Investors LLC - MarketBeat
Firetrail Investments PTY Ltd. Grows Position in Icon Plc $ICLR - MarketBeat
Two Creeks Capital Management, LP's Icon PLC(ICLR) Holding History - GuruFocus
HBK Sorce Advisory LLC Purchases Shares of 2,829 Icon Plc $ICLR - MarketBeat
Arkadios Wealth Advisors Buys 2,354 Shares of Icon Plc $ICLR - MarketBeat
Oppenheimer Asset Management Inc. Sells 9,690 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Fisher Funds Management LTD - MarketBeat
ICON suspends COVID vaccine study after BARDA notice - MSN
Buckhead Capital Management LLC Increases Stock Position in Icon Plc $ICLR - MarketBeat
Live Oak Private Wealth LLC Purchases 3,277 Shares of Icon Plc $ICLR - MarketBeat
Icon PLC (ICLR) Stock Price, Trades & News - GuruFocus
New Phase 2b Trial by Icon Plc and Bavarian Nordic: A Closer Look at MVA-BN Vaccine Developments - MSN
Clinical Real World Data Market Set to Witness Massive Growth - openPR.com
Icon (ICLR) Shares Cross Below 200 DMA - Nasdaq
Pettee Investors Inc. Trims Stock Position in Icon Plc $ICLR - MarketBeat
First Pacific Advisors LP Increases Position in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Peregrine Capital Management LLC - MarketBeat
5,284 Shares in Icon Plc $ICLR Purchased by Brighton Jones LLC - MarketBeat
Icon Plc (NASDAQ:ICLR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Motley Fool Wealth Management LLC Grows Position in Icon Plc $ICLR - MarketBeat
ICON plc Reports Third Quarter 2025 Financial Results - MSN
Evercore Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $220 - 富途牛牛
Kornitzer Capital Management Inc. KS Reduces Holdings in Icon Plc $ICLR - MarketBeat
ICON plc’s Earnings Call: Balancing Growth and Challenges - The Globe and Mail
ICON plc Experiences Valuation Adjustment Amidst Challenging Market Conditions - Markets Mojo
Icon Plc $ICLR Stock Holdings Decreased by Envestnet Portfolio Solutions Inc. - MarketBeat
ICON plc (ICLR) Stock forecasts - Yahoo! Finance UK
ICON plc (ICLR) Stock Forecasts - Yahoo Finance
Icon (NASDAQ:ICLR) Shares Down 8.7%Time to Sell? - MarketBeat
ICON (ICLR) Margin Expansion Reinforces Bullish Narratives Despite Slower Revenue Outlook - Sahm
Truist Trims Price Target on ICON PLC to $231 From $234, Keeps Buy Rating - MarketScreener
Deutsche Bank Trims Price Target on ICON PLC to $205 From $210, Keeps Buy Rating - MarketScreener
A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $220 to $231 - 富途牛牛
ICON PLC : Deutsche Bank Cuts Target Price to $205 From $210 - 富途牛牛
Whittier Trust Co. Has $257,000 Stock Position in Icon Plc $ICLR - MarketBeat
ICON plc Reports Steady Q3 2025 Growth Amid Challenges - TipRanks
ICON PLC : TD Cowen Cuts Target Price to $172 From $183 - 富途牛牛
Icon PLC (ICLR) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Competitive Pressures By GuruFocus - Investing.com Canada
ICON Announces CEO Transition and Updates on Share Repurchase and Vaccine Study - TipRanks
ICLR posts Q3 revenue of $2.04B amid $165.3M impairment - Stock Titan
Leerink Partners Maintains Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $220 - 富途牛牛
Icon PLC (ICLR) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Competitive Pressures - Yahoo Finance
Earnings Call Summary | Icon PLC(ICLR.US) Q3 2025 Earnings Conference - 富途牛牛
Earnings call transcript: ICON PLC beats Q3 2025 earnings expectations By Investing.com - Investing.com Nigeria
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating - 富途牛牛
Earnings call transcript: ICON PLC beats Q3 2025 earnings expectations - Investing.com
ICON PLC earnings beat by $0.01, revenue topped estimates - Investing.com South Africa
Icon PLC: Q3 Earnings Snapshot - theheraldreview.com
William Blair Maintains Icon PLC(ICLR.US) With Buy Rating - 富途牛牛
ICON PLC earnings beat by $0.01, revenue topped estimates By Investing.com - Investing.com Australia
ICON PLC reports results for the quarter ended September 30Earnings Summary - TradingView
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
6.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):